A randomized, double-blind, single-dose study, placebo-controlled evaluation of the safety and efficacy of intravenous lornoxicam in the acute treatment of the headache of migraine.

Trial Profile

A randomized, double-blind, single-dose study, placebo-controlled evaluation of the safety and efficacy of intravenous lornoxicam in the acute treatment of the headache of migraine.

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Nov 2012

At a glance

  • Drugs Lornoxicam (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Sponsors POZEN
  • Most Recent Events

    • 30 Nov 2012 Actual end date Apr 2006 added as reported by ClinicalTrials.gov.
    • 23 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top